Avalo Therapeutics (AVTX) Institutional Ownership → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free AVTX Stock Alerts $9.59 -0.05 (-0.52%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Avalo Therapeutics (NASDAQ:AVTX)CurrentInstitutional OwnershipPercentage87.06%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$30.75MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$45.50K Get AVTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Avalo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AVTX Institutional Buying and Selling by Quarter Ad The Freeport SocietyNext President (Not Trump. Not Biden.)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.Click here to see why it will be ______ _________. Avalo Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/17/2024 Ikarian Capital LLC46,648$1.02M0.1%N/A4.511% 5/15/2024 Affinity Asset Advisors LLC10,000$218K0.0%N/A0.971% 5/14/2024 Natixis2,512$55K0.0%-45.4%0.244% 11/13/2023 Acadian Asset Management LLC283,306$34K0.0%N/A1.399% 8/11/2023 VR Adviser LLC1,250,000$444K0.1%+25.0%6.173% 5/16/2023 Great Point Partners LLC474,639$831K0.2%N/A3.595% Get the Latest News and Ratings for AVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/5/2023 Monashee Investment Management LLC60,000$105K0.0%N/A0.455% 2/15/2023 Nantahala Capital Management LLC540,667$2.73M0.2%-1.3%5.746% 11/14/2022 Armistice Capital LLC3,964,666$13.16M0.2%-91.7%42.115% 11/14/2022 Point72 Asset Management L.P.500,737$1.66M0.0%-91.7%5.319% 11/10/2022 Nantahala Capital Management LLC547,814$1.82M0.1%-91.8%5.819% 10/27/2022 Assenagon Asset Management S.A.15,646$52K0.0%N/A0.166% 8/15/2022 Nantahala Capital Management LLC6,710,327$3.36M0.2%-2.0%71.280% 8/15/2022 Opaleye Management Inc.450,000$225K0.1%-69.1%4.780% 5/12/2022 Integral Health Asset Management LLC700,000$507K0.1%-56.9%0.621% 5/3/2022Leo Brokerage LLC62,629$45K0.0%N/A0.056% 4/25/2022 Assenagon Asset Management S.A.42,338$31K0.0%-92.7%0.038% 2/15/2022 Stonepine Capital Management LLC1,510,095$2.57M1.2%+77.7%1.344% 2/15/2022 LGL Partners LLC28,850$49K0.0%N/A0.026% 2/14/2022 Freestone Capital Holdings LLC20,000$34K0.0%N/A0.018% 2/14/2022 Soleus Capital Management L.P.770,000$1.31M0.1%N/A0.686% 2/8/2022 Northern Trust Corp533,578$907K0.0%+3.1%0.475% 2/1/2022 Assenagon Asset Management S.A.582,718$991K0.0%-33.7%0.519% 1/24/2022 Strs Ohio38,400$65K0.0%-40.2%0.034% 1/20/2022Minot Wealth Management LLC34,645$59K0.0%-66.5%0.031% 12/29/2021 Hudson Bay Capital Management LP197,133$430K0.0%N/A0.176% 11/16/2021 Opaleye Management Inc.1,459,400$3.18M0.6%N/A1.299% 11/16/2021 Squarepoint Ops LLC18,657$41K0.0%N/A0.017% 11/16/2021 Two Sigma Advisers LP801,300$1.75M0.0%N/A0.713% 11/16/2021 Two Sigma Investments LP732,931$1.60M0.0%N/A0.653% 11/16/2021 Laurion Capital Management LP330,444$720K0.0%N/A0.294% 11/15/2021 Point72 Asset Management L.P.6,008,850$13.10M0.1%N/A5.350% 11/15/2021 Atom Investors LP27,507$60K0.0%N/A0.024% 11/15/2021 Voya Investment Management LLC21,854$48K0.0%N/A0.019% 11/15/2021 Caas Capital Management LP11,812$26K0.0%N/A0.011% 11/12/2021 Aristides Capital LLC48,953$107K0.0%N/A0.044% 11/12/2021 Stonepine Capital Management LLC850,000$1.85M0.8%N/A0.770% 11/12/2021 Geode Capital Management LLC1,242,382$2.71M0.0%N/A1.126% 11/12/2021 Integral Health Asset Management LLC1,625,000$3.54M1.0%N/A1.473% 11/10/2021 Goldman Sachs Group Inc.672,664$1.47M0.0%N/A0.610% Obama’s Forever Term [exposed] (Ad)America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.Start streaming it now at no cost here11/10/2021 Creative Planning14,814$32K0.0%N/A0.013% 11/10/2021 Alliancebernstein L.P.19,100$42K0.0%N/A0.017% 11/9/2021 BlackRock Inc.3,716,943$8.10M0.0%N/A3.369% 11/9/2021 Monashee Investment Management LLC270,000$589K0.1%N/A0.245% 11/8/2021 Meeder Asset Management Inc.19,260$43K0.0%N/A0.017% 11/4/2021Asymmetry Capital Management L.P.534,621$1.17M0.7%N/A0.485% 11/4/2021 Deutsche Bank AG31,794$69K0.0%N/A0.029% 11/2/2021 Cambridge Investment Research Advisors Inc.12,164$27K0.0%N/A0.011% 11/2/2021 New York State Common Retirement Fund22,214$48K0.0%N/A0.020% 11/2/2021 Victory Capital Management Inc.15,788$34K0.0%N/A0.014% 11/1/2021 SG Americas Securities LLC18,596$41K0.0%N/A0.017% 10/29/2021Commonwealth Equity Services LLC52,000$113K0.0%N/A0.047% 10/25/2021Minot Wealth Management LLC103,410$225K0.0%N/A0.094% 10/22/2021 Strs Ohio64,200$139K0.0%N/A0.058% 10/19/2021 Assenagon Asset Management S.A.879,334$1.92M0.0%N/A0.797% 10/19/2021 Tamar Securities LLC23,084$50K0.0%N/A0.021% (Data available from 1/1/2016 forward) AVTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AVTX shares? During the previous two years, 12 institutional investors and hedge funds held shares of Avalo Therapeutics. The most heavily invested institutionals were Armistice Capital LLC ($13.16M), Nantahala Capital Management LLC ($2.73M), Point72 Asset Management L.P. ($1.66M), Ikarian Capital LLC ($1.02M), Great Point Partners LLC ($831K), VR Adviser LLC ($444K), and Opaleye Management Inc. ($225K).Learn more on AVTX's institutional investors. What percentage of Avalo Therapeutics stock is owned by institutional investors? 87.06% of Avalo Therapeutics stock is owned by institutional investors. Learn more on AVTX's institutional investor holdings. Which institutional investors have been buying Avalo Therapeutics stock? The following institutional investors have purchased Avalo Therapeutics stock in the last 24 months: Great Point Partners LLC ($474.64K), Acadian Asset Management LLC ($283.31K), VR Adviser LLC ($250K), Monashee Investment Management LLC ($60K), Ikarian Capital LLC ($46.65K), Assenagon Asset Management S.A. ($15.65K), and Affinity Asset Advisors LLC ($10K). How much institutional buying is happening at Avalo Therapeutics? Institutional investors have bought a total of 1,140,239 shares in the last 24 months. This purchase volume represents approximately $267.77M in transactions. Which Avalo Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Avalo Therapeutics stock in the last 24 months: Armistice Capital LLC ($43.61M), Nantahala Capital Management LLC ($6.31M), Point72 Asset Management L.P. ($5.51M), Opaleye Management Inc. ($1.00M), and Natixis ($2.09K). How much institutional selling is happening at Avalo Therapeutics? Institutional investors have sold a total of 56,434,819 shares in the last 24 months. This volume of shares sold represents approximately $45.70B in transactions. Related Companies: RedHill Biopharma Institutional Ownership Pieris Pharmaceuticals Institutional Ownership Monopar Therapeutics Institutional Ownership Kiora Pharmaceuticals Institutional Ownership Purple Biotech Institutional Ownership FSD Pharma Institutional Ownership Edesa Biotech Institutional Ownership Elevai Labs Institutional Ownership Akari Therapeutics Institutional Ownership Moleculin Biotech Institutional Ownership This page (NASDAQ:AVTX) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetry41 banks launch ‘crypto dollar’Stansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.